logo-loader
RNS
viewAvino

Antisoma plc - Notice of Interim Results

Notice of Interim Results Notification of Interim Results 23 January 2009, London, UK and Cambridge, MA: - Antisoma plc (LSE: ASM; USOTC: ATSMY) will be announcing its interim results for the six months ended 31 December 2008 on Monday 16th February 2009. Enquiries: Daniel Elger VP, Marketing and Communications Antisoma plc +44 (0)20 3249 2100 Mark Court/Lisa Baderoon/Rebecca Skye Dietrich Buchanan Communications +44 (0)20 7466 5000 Background on Antisoma Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma. ---END OF MESSAGE--- This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Quick facts: Avino

Price: -

Market: TSX-V
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS